Syngene International Limited
Government Pension Fund Global (Norway), which previously held 1.82 percent of Syngene International Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in its stake below the 1 percent reporting threshold.
India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.